Details About the Webinar

Thursday, 27/11/2025 · 09:00 London (GMT +0:00)
Cost: Free
 Add to calendar

Liver cancer is the sixth most common cancer and the third leading cause of cancer-related mortality globally. The number of new liver cancer cases will nearly double, from 0.87 million in 2022 to 1.52 million in 2050, if there is no change in the current trend.

This Lancet Webinar will cover:

  • An overview of The Lancet Commission on addressing the global HCC burden and its comprehensive strategies from prevention to treatment.

  • How the global community is tackling the rising trend of liver cancer.

  • The differences in liver cancer epidemiology and management across different regions.

  • The emerging threat of metabolic dysfunction-associated steatotic liver diseases (MASH) and its implications.

    • This webinar aims to foster a global dialogue among healthcare professionals, researchers, and policymakers, and to explore innovative approaches to reduce the burden of liver cancer worldwide.

About the Speakers

1756208547-37a8e0d370f6dc89 Helena Wang
Asia Senior Executive Editor, The Lancet, China

Helena Wang was the first China-based editor at The Lancet Group. She joined The Lancet as the Asia Editor in 2010, and became the Asia Executive Editor in 2016. Helena had led several editorial projects, including The Lancet-Chinese Academy of Medical Sciences Medical Conferences, The Lancet China themed issues, The Lancet China relevant Commissions, and The Wakley-Wu Lien Teh prize. She was also a Council Member of COPE (Committee of Publishing Ethics) from 2016-2019. Helena was initially trained to be a medical doctor in Tongji Medical College of Huazhong University of Science and Technology (China) and obtained her medical degree in 2000. She also has a Master's degree in Pathology and Pathophysiology from Tongji Medical College of Huazhong University of Science and Technology (China), specialising in Alzheimer's disease.

1756724110-940c0f0f2f7d3796 Vania Wisdom
Senior Executive Editor and Oncology Ambassador, The Lancet, UK

Vania Wisdom is a Senior Executive Editor at The Lancet, where she oversees the Fast-Track peer-review service and is involved in the overall strategy of the journal. Vania handles peer review and commissioning across a broad range of topics, but her main area of interest is cancer. She oversees the oncology strategy for the journal as the Oncology Ambassador. Vania has been the editorial lead for several Lancet Commissions including The Lancet Commission on Women, Power and Cancer, The Lancet Commission on Prostate Cancer launch, and the ongoing Lancet Commission on Cancer and Healthcare Systems. Before joining The Lancet Group, she had a strong academic and award-winning scientific career as a researcher in oncology, in the UK, Germany and Portugal. She is now based in London, UK

1756814852-9a40c3d60a72771a Jian Zhou
Professor, Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, China

Jian Zhou is a Professor of Surgery and President of Zhongshan Hospital, Fudan University (China). He is also Executive Vice Director of the Liver Cancer Institute at Fudan University (China). Jian is Chairman Designate of the Chinese Society of Oncology, Chinese Medical Association, and President of the Asia-Pacific Primary Liver Cancer Expert Association (APPLE). He is also co-Chair of The Lancet Commission on addressing the global HCC burden.

1756815133-6b397be9319dee91 Stephen Lam Chan
Professor, Department of Clinical Oncology, Chinese University of Hong Kong, China

Stephen Lam Chan is a Clinical Professor in the Department of Clinical Oncology at the Chinese University of Hong Kong (China). He is renowned for his clinical and translational research on hepatobiliary and pancreatic cancers. Professor Chan has authored over 260 papers published in peer-reviewed journals. Internationally, he has served on the scientific committees of ASCO and ESMO conferences, and is currently the President-Elect of the International Liver Cancer Association (ILCA). Professor Chan is an Associate Editor for journals such as the Journal of Hepatology. Locally, he is a Board Director of the Chinese University of Hong Kong Medical Centre and the Assistant Dean (Health Systems) of the Faculty of Medicine at the Chinese University of Hong Kong (China). He also established the Hand in Hand Cancer Foundation, a charity dedicated to serving patients in need.

1756815313-9820709cbfb0727b Jordi Bruix
Professor, Barcelona Clinic Liver Cancer (BCLC), Hospital Clínic Barcelona, IDIBAPS, Spain

Dr Jordi Bruix has developed his career around liver cancer. Under his leadership, the BCLC Group has conducted major studies about epidemiology, molecular profile, diagnosis, prognosis, and treatment of hepatocellular carcinoma. The results of such studies have allowed the development of the BCLC prognosis and treatment strategy for hepatocellular carcinoma that is endorsed by major scientific associations. He has received scientific awards from EASL, AASLD, and ILCA.

1756815639-4b972eff7272f579 Hongmei Zeng
Professor, National Central Cancer Registry, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China

Dr Hongmei Zeng earned her PhD in Epidemiology and Biostatistics from Peking University (China) and was a visiting scholar at Yale University (USA) from 2009-2010 and at Harvard University (USA) from 2019-2020. With over 14 years of experience in cancer surveillance and epidemiology, she has been a core member of China's National Cancer Registration and Follow-up Program. She pioneered methodologies for the country's first multi-centre, population-based cancer survival research and has consistently advanced innovative approaches for improving cancer registration and data utilisation. Her contributions have been recognised internationally, earning her the Best Young Investigator Award at the The Lancet-CAMS Health Summit (2015), the Excellence Oral Presentation Award at the 9th General Assembly and International Conference of Asian Pacific Organization for Cancer Prevention (2018), and the Young Investigator Award at the 13th Asian-Pacific Primary Liver Cancer Expert Meeting (2023).

1756916638-fb207e87ef70067c Presented in partnership with
London Global Cancer Week


Contact Info

Lancet Webinars
Join our Lancet Webinar
First Name*
Last Name*
Email Address*
Country*
Profession*
Job title*
Career stage*
Lancet Webinar Event Permission
The Lancet Group will use the information you provide on this form to be in touch with you and to provide updates relating to this Lancet Webinar event. We will not share or sell your personal information. For more information, please read our privacy policy.
Privacy Policy
✓ Yes, I consent to receiving emails about this Lancet Webinar*
Marketing Permission
The Lancet Group will use the information you provide on this form to be in touch with you and to provide updates and marketing. We will not share or sell your personal information. You can unsubscribe anytime by clicking the unsubscribe link in the footer of our emails. For more information, please read our privacy policy.
Privacy Policy
✓ Yes, I consent to receiving marketing emails from The Lancet Group
By registering, you consent to receiving communications from The Lancet Group relating to this Lancet Webinar. You can unsubscribe from these emails at any time using the unsubscribe link at the bottom of the emails.